LOW DOSE VALGANCICLOVIR AS A PRE-EMPTIVE THERAPY IS EFFECTIVE FOR CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANTATION: A SINGLE-CENTER EXPERIENCE

被引：0
|
作者：
Jeon, Jin Seok [1 ]
Lee, Haekyung [1 ]
Kim, Hyoungnae [1 ]
Kwon, Soon Hyo [1 ]
Noh, Hyunjin [1 ]
机构：
[1] Soonchunhyang Univ Hosp, Dept Internal Med, Seoul, South Korea
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
5364
引用
收藏
页码：I1236 / I1236
页数：1
相关论文
共 50 条
  • [21] Pre-emptive therapy with valganciclovir for cytomegalovirus (CMV) infection after allogeneic haematopoietic stem cell transplantation (Allo-HSCT)
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Ilhan, O.
    Akan, H.
    Uysal, A.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S322 - S323
  • [22] Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant. Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience
    Favi, E.
    Santangelo, R.
    Iesari, S.
    Morandi, M.
    Marcovecchio, G. E.
    Trecarichi, E. M.
    Salerno, M. P.
    Ferraresso, M.
    Citterio, F.
    Romagnoli, J.
    TRANSPLANTATION PROCEEDINGS, 2017, 49 (08) : 1766 - 1772
  • [23] Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single-center experience
    Tamura, Sumihito
    Sugawara, Yasuhiko
    Yamashiki, Noriyo
    Kaneko, Junichi
    Kokudo, Norihiro
    Makuuchi, Masatoshi
    TRANSPLANT INTERNATIONAL, 2010, 23 (06) : 580 - 588
  • [24] Valganciclovir as pre-emptive therapy for cytomegalovirus infection post-allogenic stem cell transplantation: implications for the emergence of drug-resistant cytomegalovirus
    Allice, Tiziano
    Busca, Alessandro
    Locatelli, Franco
    Falda, Michele
    Pittaluga, Fabrizia
    Ghisetti, Valeria
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (03) : 600 - 608
  • [25] Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
    Ozcelik, Umit
    Alpay, Nadir
    Eren, Eryigit
    Uslu, Bora
    Yardimci, Ahmet Cem
    HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, 2020, 58 (01): : 27 - 32
  • [26] Advantages and Disadvantages of Pre-emptive Kidney Transplantation: Results From a Single Transplantation Center
    Nakamura, T.
    Ushigome, H.
    Nakao, T.
    Harada, S.
    Koshino, K.
    Suzuki, T.
    Ito, T.
    Nobori, S.
    Yoshimura, N.
    TRANSPLANTATION PROCEEDINGS, 2015, 47 (03) : 626 - 629
  • [27] Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective Analysis
    Farkas, Katalin
    Varga, Marina
    Dinnyes, Izabella
    Rem, Lili
    Telkes, Gabor
    Wagner, Laszlo
    Remport, Adam
    Piros, Laszlo
    Szijarto, Attila
    Huszty, Gergely
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (01) : 105 - 110
  • [28] THE USAGE OF ORAL VALGANCICLOVIR FOR THE PRE-EMPTIVE TREATMENT OF CYTOMEGALOVIRUS INFECTION AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN
    Karakukcu, M.
    Isik, B.
    Unal, E.
    Yilmaz, E.
    Mutlu, F. Turkan
    Kirkas, O. Gul
    Ceylan, O.
    Patiroglu, T.
    Ozdemir, M. Akif
    BONE MARROW TRANSPLANTATION, 2014, 49 : S470 - S470
  • [29] The Value of Pre-emptive Therapy for Cytomegalovirus after Liver Transplantation
    Mueller, V.
    Perrakis, A.
    Meyer, J.
    Foertsch, T.
    Korn, K.
    Croner, R. S.
    Yedibela, S.
    Hohenberger, W.
    Schellerer, V. S.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (05) : 1357 - 1361
  • [30] Oral valganciclovir is an effective primary pre-emptive therapy of cytomegalovirus disease in recipients of allogeneic stem cell transplant
    Candoni, A.
    Mestroni, R.
    Simeone, E.
    Cerno, M.
    Fanin, R.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S175 - S176
12345